UNSPSC 51332865: Perphenazine hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C21H26ClN3OS.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 667C5N7677, chemically known as 1-piperazineethanol, 4-(3-(2-chloro-10h-phenothiazin-10-yl)propyl)-, hydrochloride (1:1), but more generally known as perphenazine hydrochloride, which bears US NIH Compound Identifier 76557. European Medicines Agency schedules perphenazine hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09736MIG.

Most nations, for tariff purposes, schedule perphenazine hydrochloride under HS 29343090. SMILES: C1CCC2C(C1)N(C3C(CCCC3CL)S2)CCCN4CCN(CC4)CCO.CL.

UNSPSC 51332865 Perphenazine hydrochloride is a Commodity code that appears to capture pharmaceutical products used in state and local health and emergency services. However, the recent solicitation activity under this code does not reflect the nominal scope. Seminole County, Florida issued an IFB (60459723LAS) in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—neither of which corresponds to perphenazine hydrochloride, an antipsychotic medication. The mismatch suggests either a cataloging error in the state-local procurement system or that this code has been misapplied to the opportunity. The Seminole County solicitation is designed to support community health initiatives through quarterly deliveries to the county's Community Health Building in Sanford, Florida, with electronic bidding through the county's e-Procurement Portal. Vendors must include all shipping and delivery costs, maintain drug-free workplace certification and E-Verify compliance, carry workers' compensation and commercial general liability insurance, and meet potential FEMA compliance requirements if the procurement is federally funded.

The single recent opportunity available does not establish a pattern of issuing-body or geographic concentration. Seminole County represents the only identified recent activity under this code. The original IFB posting date of June 30, 2026 with a response deadline of July 26, 2023 contains an apparent date inconsistency in the source material. Because the solicitation tracked to this code involves naloxone and drug deactivation systems rather than perphenazine, the code shows minimal relevant recent activity aligned with its pharmaceutical scope. Business development professionals should verify the correct UNSPSC classification before pursuing opportunities in perphenazine procurement or clarify whether naloxone and related harm-reduction products are the intended commodity focus.